Growing evidences indicate that serum levels of OPG are significantly increased in both diabetic and non-diabetic patients susceptible to atherosclerosis or vascular dysfunction (Simonet et al., 1997; Schoppet et al., 2002, 2004; Tousoulis et al., 2013). This evidence concerns the gene TNFRSF11B and atherosclerosis.